Global Aneurysm Therapeutics Market Size, Status and Forecast 2020-2026

SKU ID :QYR-15133587 | Published Date: 28-Jan-2020 | No. of pages: 94
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Aneurysm Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Aneurysm Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Medicine 1.4.3 Surgery 1.4.4 Other 1.5 Market by Application 1.5.1 Global Aneurysm Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Aneurysm Therapeutics Market Perspective (2015-2026) 2.2 Aneurysm Therapeutics Growth Trends by Regions 2.2.1 Aneurysm Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Aneurysm Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Aneurysm Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Aneurysm Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Aneurysm Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Aneurysm Therapeutics Players by Market Size 3.1.1 Global Top Aneurysm Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Aneurysm Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Aneurysm Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Aneurysm Therapeutics Market Concentration Ratio 3.2.1 Global Aneurysm Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Aneurysm Therapeutics Revenue in 2019 3.3 Aneurysm Therapeutics Key Players Head office and Area Served 3.4 Key Players Aneurysm Therapeutics Product Solution and Service 3.5 Date of Enter into Aneurysm Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Aneurysm Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Aneurysm Therapeutics Forecasted Market Size by Type (2021-2026) 5 Aneurysm Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Aneurysm Therapeutics Market Size by Application (2015-2020) 5.2 Global Aneurysm Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Aneurysm Therapeutics Market Size (2015-2020) 6.2 Aneurysm Therapeutics Key Players in North America (2019-2020) 6.3 North America Aneurysm Therapeutics Market Size by Type (2015-2020) 6.4 North America Aneurysm Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Aneurysm Therapeutics Market Size (2015-2020) 7.2 Aneurysm Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Aneurysm Therapeutics Market Size by Type (2015-2020) 7.4 Europe Aneurysm Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Aneurysm Therapeutics Market Size (2015-2020) 8.2 Aneurysm Therapeutics Key Players in China (2019-2020) 8.3 China Aneurysm Therapeutics Market Size by Type (2015-2020) 8.4 China Aneurysm Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Aneurysm Therapeutics Market Size (2015-2020) 9.2 Aneurysm Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Aneurysm Therapeutics Market Size by Type (2015-2020) 9.4 Japan Aneurysm Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Aneurysm Therapeutics Market Size (2015-2020) 10.2 Aneurysm Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Aneurysm Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Aneurysm Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Aneurysm Therapeutics Market Size (2015-2020) 11.2 Aneurysm Therapeutics Key Players in India (2019-2020) 11.3 India Aneurysm Therapeutics Market Size by Type (2015-2020) 11.4 India Aneurysm Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Aneurysm Therapeutics Market Size (2015-2020) 12.2 Aneurysm Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Aneurysm Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Aneurysm Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 GE Healthcare 13.1.1 GE Healthcare Company Details 13.1.2 GE Healthcare Business Overview and Its Total Revenue 13.1.3 GE Healthcare Aneurysm Therapeutics Introduction 13.1.4 GE Healthcare Revenue in Aneurysm Therapeutics Business (2015-2020)) 13.1.5 GE Healthcare Recent Development 13.2 Endologix 13.2.1 Endologix Company Details 13.2.2 Endologix Business Overview and Its Total Revenue 13.2.3 Endologix Aneurysm Therapeutics Introduction 13.2.4 Endologix Revenue in Aneurysm Therapeutics Business (2015-2020) 13.2.5 Endologix Recent Development 13.3 JOTEC 13.3.1 JOTEC Company Details 13.3.2 JOTEC Business Overview and Its Total Revenue 13.3.3 JOTEC Aneurysm Therapeutics Introduction 13.3.4 JOTEC Revenue in Aneurysm Therapeutics Business (2015-2020) 13.3.5 JOTEC Recent Development 13.4 Lombard Medical 13.4.1 Lombard Medical Company Details 13.4.2 Lombard Medical Business Overview and Its Total Revenue 13.4.3 Lombard Medical Aneurysm Therapeutics Introduction 13.4.4 Lombard Medical Revenue in Aneurysm Therapeutics Business (2015-2020) 13.4.5 Lombard Medical Recent Development 13.5 Terumo Medical 13.5.1 Terumo Medical Company Details 13.5.2 Terumo Medical Business Overview and Its Total Revenue 13.5.3 Terumo Medical Aneurysm Therapeutics Introduction 13.5.4 Terumo Medical Revenue in Aneurysm Therapeutics Business (2015-2020) 13.5.5 Terumo Medical Recent Development 13.6 Cardinal Health 13.6.1 Cardinal Health Company Details 13.6.2 Cardinal Health Business Overview and Its Total Revenue 13.6.3 Cardinal Health Aneurysm Therapeutics Introduction 13.6.4 Cardinal Health Revenue in Aneurysm Therapeutics Business (2015-2020) 13.6.5 Cardinal Health Recent Development 13.7 Cook Medical Devices 13.7.1 Cook Medical Devices Company Details 13.7.2 Cook Medical Devices Business Overview and Its Total Revenue 13.7.3 Cook Medical Devices Aneurysm Therapeutics Introduction 13.7.4 Cook Medical Devices Revenue in Aneurysm Therapeutics Business (2015-2020) 13.7.5 Cook Medical Devices Recent Development 13.8 Medtronic 13.8.1 Medtronic Company Details 13.8.2 Medtronic Business Overview and Its Total Revenue 13.8.3 Medtronic Aneurysm Therapeutics Introduction 13.8.4 Medtronic Revenue in Aneurysm Therapeutics Business (2015-2020) 13.8.5 Medtronic Recent Development 13.9 Lifetech Scientific 13.9.1 Lifetech Scientific Company Details 13.9.2 Lifetech Scientific Business Overview and Its Total Revenue 13.9.3 Lifetech Scientific Aneurysm Therapeutics Introduction 13.9.4 Lifetech Scientific Revenue in Aneurysm Therapeutics Business (2015-2020) 13.9.5 Lifetech Scientific Recent Development 13.10 Gore Medical 13.10.1 Gore Medical Company Details 13.10.2 Gore Medical Business Overview and Its Total Revenue 13.10.3 Gore Medical Aneurysm Therapeutics Introduction 13.10.4 Gore Medical Revenue in Aneurysm Therapeutics Business (2015-2020) 13.10.5 Gore Medical Recent Development 13.11 Pfizer 10.11.1 Pfizer Company Details 10.11.2 Pfizer Business Overview and Its Total Revenue 10.11.3 Pfizer Aneurysm Therapeutics Introduction 10.11.4 Pfizer Revenue in Aneurysm Therapeutics Business (2015-2020) 10.11.5 Pfizer Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
List of Tables Table 1. Aneurysm Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Aneurysm Therapeutics Revenue Table 3. Ranking of Global Top Aneurysm Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Aneurysm Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Medicine Table 6. Key Players of Surgery Table 7. Key Players of Other Table 8. Global Aneurysm Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Aneurysm Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Aneurysm Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Aneurysm Therapeutics Market Share by Regions (2015-2020) Table 12. Global Aneurysm Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Aneurysm Therapeutics Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Aneurysm Therapeutics Market Growth Strategy Table 18. Main Points Interviewed from Key Aneurysm Therapeutics Players Table 19. Global Aneurysm Therapeutics Revenue by Players (2015-2020) (Million US$) Table 20. Global Aneurysm Therapeutics Market Share by Players (2015-2020) Table 21. Global Top Aneurysm Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysm Therapeutics as of 2019) Table 22. Global Aneurysm Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Aneurysm Therapeutics Product Solution and Service Table 25. Date of Enter into Aneurysm Therapeutics Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 28. Global Aneurysm Therapeutics Market Size Share by Type (2015-2020) Table 29. Global Aneurysm Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Aneurysm Therapeutics Market Size Share by Application (2015-2020) Table 31. Global Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 32. Global Aneurysm Therapeutics Market Size Share by Application (2021-2026) Table 33. North America Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 34. North America Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 35. North America Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 36. North America Aneurysm Therapeutics Market Share by Type (2015-2020) Table 37. North America Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 38. North America Aneurysm Therapeutics Market Share by Application (2015-2020) Table 39. Europe Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 41. Europe Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 42. Europe Aneurysm Therapeutics Market Share by Type (2015-2020) Table 43. Europe Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 44. Europe Aneurysm Therapeutics Market Share by Application (2015-2020) Table 45. China Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 46. China Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 47. China Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 48. China Aneurysm Therapeutics Market Share by Type (2015-2020) Table 49. China Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 50. China Aneurysm Therapeutics Market Share by Application (2015-2020) Table 51. Japan Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 53. Japan Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 54. Japan Aneurysm Therapeutics Market Share by Type (2015-2020) Table 55. Japan Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 56. Japan Aneurysm Therapeutics Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 59. Southeast Asia Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Aneurysm Therapeutics Market Share by Type (2015-2020) Table 61. Southeast Asia Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Aneurysm Therapeutics Market Share by Application (2015-2020) Table 63. India Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 64. India Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 65. India Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 66. India Aneurysm Therapeutics Market Share by Type (2015-2020) Table 67. India Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 68. India Aneurysm Therapeutics Market Share by Application (2015-2020) Table 69. Central & South America Key Players Aneurysm Therapeutics Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Aneurysm Therapeutics Market Share (2019-2020) Table 71. Central & South America Aneurysm Therapeutics Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Aneurysm Therapeutics Market Share by Type (2015-2020) Table 73. Central & South America Aneurysm Therapeutics Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Aneurysm Therapeutics Market Share by Application (2015-2020) Table 75. GE Healthcare Company Details Table 76. GE Healthcare Business Overview Table 77. GE Healthcare Product Table 78. GE Healthcare Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 79. GE Healthcare Recent Development Table 80. Endologix Company Details Table 81. Endologix Business Overview Table 82. Endologix Product Table 83. Endologix Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 84. Endologix Recent Development Table 85. JOTEC Company Details Table 86. JOTEC Business Overview Table 87. JOTEC Product Table 88. JOTEC Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 89. JOTEC Recent Development Table 90. Lombard Medical Company Details Table 91. Lombard Medical Business Overview Table 92. Lombard Medical Product Table 93. Lombard Medical Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 94. Lombard Medical Recent Development Table 95. Terumo Medical Company Details Table 96. Terumo Medical Business Overview Table 97. Terumo Medical Product Table 98. Terumo Medical Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 99. Terumo Medical Recent Development Table 100. Cardinal Health Company Details Table 101. Cardinal Health Business Overview Table 102. Cardinal Health Product Table 103. Cardinal Health Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 104. Cardinal Health Recent Development Table 105. Cook Medical Devices Company Details Table 106. Cook Medical Devices Business Overview Table 107. Cook Medical Devices Product Table 108. Cook Medical Devices Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 109. Cook Medical Devices Recent Development Table 110. Medtronic Business Overview Table 111. Medtronic Product Table 112. Medtronic Company Details Table 113. Medtronic Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 114. Medtronic Recent Development Table 115. Lifetech Scientific Company Details Table 116. Lifetech Scientific Business Overview Table 117. Lifetech Scientific Product Table 118. Lifetech Scientific Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 119. Lifetech Scientific Recent Development Table 120. Gore Medical Company Details Table 121. Gore Medical Business Overview Table 122. Gore Medical Product Table 123. Gore Medical Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 124. Gore Medical Recent Development Table 125. Pfizer Company Details Table 126. Pfizer Business Overview Table 127. Pfizer Product Table 128. Pfizer Revenue in Aneurysm Therapeutics Business (2015-2020) (Million US$) Table 129. Pfizer Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Aneurysm Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Medicine Features Figure 3. Surgery Features Figure 4. Other Features Figure 5. Global Aneurysm Therapeutics Market Share by Application: 2020 VS 2026 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Other Case Studies Figure 9. Aneurysm Therapeutics Report Years Considered Figure 10. Global Aneurysm Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Aneurysm Therapeutics Market Share by Regions: 2020 VS 2026 Figure 12. Global Aneurysm Therapeutics Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Aneurysm Therapeutics Market Share by Players in 2019 Figure 15. Global Top Aneurysm Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysm Therapeutics as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Aneurysm Therapeutics Revenue in 2019 Figure 17. North America Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Aneurysm Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. GE Healthcare Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 26. Endologix Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Endologix Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 28. JOTEC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. JOTEC Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 30. Lombard Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Lombard Medical Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 32. Terumo Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Terumo Medical Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 34. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Cardinal Health Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 36. Cook Medical Devices Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Cook Medical Devices Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 38. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Medtronic Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 40. Lifetech Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Lifetech Scientific Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 42. Gore Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Gore Medical Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 44. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Pfizer Revenue Growth Rate in Aneurysm Therapeutics Business (2015-2020) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed
GE Healthcare Endologix JOTEC Lombard Medical Terumo Medical Cardinal Health Cook Medical Devices Medtronic Lifetech Scientific Gore Medical Pfizer
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients